Cheyne-Stokes Respiration: Clinical Trials

2 trials for Cheyne-Stokes Respiration, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1

Follow Cheyne-Stokes Respiration: new trials by email Literature Review of Cheyne-Stokes Respiration trials Research Report on Cheyne-Stokes Respiration

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chronic Evaluation of Respicardia Therapy
remedē (TM) system - Sleep Disordered Breathing, Cheyne Stokes Respiration
Phase 2CompletedRespicardia, Inc.572010-05-012016-05-16
Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients
AVE0657, placebo - Heart Failure, Sleep Apnea Syndromes
Phase 2TerminatedSanofi82008-06-012009-05-01

Narrower conditions

Sleep Apnea Syndromes (2)  ·  Heart Failure (1)  ·  Sleep Apnea, Central (1)

Broader conditions

Apnea (2)  ·  Dyssomnias (2)  ·  Nervous System Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiration Disorders (2)  ·  Respiratory Tract Diseases (2)  ·  Signs and Symptoms (2)  ·  Signs and Symptoms, Respiratory (2)  ·  Sleep Disorders, Intrinsic (2)  ·  Sleep Wake Disorders (2)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)

Interventions

Drug Delivery Systems (1)

Sponsors

Respicardia, Inc. (1)  ·  Sanofi (1)

Countries

Germany (2)  ·  France (1)  ·  Italy (1)  ·  Poland (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Piotr Ponikowski, MD (1)  ·  William T Abraham, MD (1)

Results publications

PMID 25770408, PMID 30325462